Informatie:
Fout:
ID
34209
Beschrijving
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver Metastases; ODM derived from: https://clinicaltrials.gov/show/NCT02419677
Link
https://clinicaltrials.gov/show/NCT02419677
Trefwoorden
Versies (1)
- 15-01-19 15-01-19 -
Houder van rechten
see on clinicaltrials.gov
Geüploaded op
15 januari 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Colorectal Cancer NCT02419677
Eligibility Colorectal Cancer NCT02419677
- StudyEvent: Eligibility
Similar models
Eligibility Colorectal Cancer NCT02419677
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
ID.1
Item
patients with histologically confirmed adenocarcinoma
boolean
ID.2
Item
primary lesions (colorectal cancer) are resected
boolean
ID.3
Item
must have undergone prior complete resection of the primary tumor; liver metastases
boolean
ID.4
Item
must be resectable or accessible for radiofrequency ablation (five or less lung metastases measuring 5 cm or smaller).
boolean
ID.5
Item
serum bilirubin level of 2.0 mg/dl or less.
boolean
ID.6
Item
performance status of 0 or 1.
boolean
ID.7
Item
expected survival of 1 year or more.
boolean
ID.8
Item
informed consent from the patient.
boolean
ID.9
Item
with extrahepatic metastases
boolean
ID.10
Item
with other neoplastic disease that is measurable or being treated other than colorectal cancer.
boolean